Bibliographic Details
| Title: |
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies. |
| Authors: |
Fracasso PM; Department of Internal Medicine, Alvin J. Siteman Cancer Center and Washington University School of Medicine, St Louis, MO, USA. fracasso@virginia.edu, Williams KJ, Chen RC, Picus J, Ma CX, Ellis MJ, Tan BR, Pluard TJ, Adkins DR, Naughton MJ, Rader JS, Arquette MA, Fleshman JW, Creekmore AN, Goodner SA, Wright LP, Guo Z, Ryan CE, Tao Y, Soares EM, Cai SR, Lin L, Dancey J, Rudek MA, McLeod HL, Piwnica-Worms H |
| Source: |
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2011 Jun; Vol. 67 (6), pp. 1225-37. Date of Electronic Publication: 2010 Aug 08. |
| Publication Type: |
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
